Mercaptopurine Tablets Shortage
Last Updated: February 21, 2024
Status: Current
Products Affected - Description
-
- Mercaptopurine tablet, Hikma, 50 mg, bottle, 25 count, NDC 00054-4581-11
- Mercaptopurine tablet, Hikma, 50 mg, bottle, 250 count, NDC 00054-4581-27
- Mercaptopurine tablet, Mylan (Viatris), 50 mg, bottle, 250 count, NDC 00378-3547-25 - discontinued
- Mercaptopurine tablet, Quinn Pharmaceuticals, 50 mg, bottle, 25 count, NDC 69076-0913-02
- Mercaptopurine tablet, Quinn Pharmaceuticals, 50 mg, bottle, 250 count, NDC 69076-0913-25
Reason for the Shortage
-
- Hikma did not provide a reason for the shortage.
- Mylan discontinued 50 mg tablets in 250 count bottles in December 2023. The 25 count bottles are available.
- Quinn has mercaptopurine tablets on shortage due to manufacturing issues.
Available Products
-
- Mercaptopurine tablet, Mylan (Viatris), 50 mg, bottle, 25 count, NDC 00378-3547-52
Estimated Resupply Dates
-
- Hikma has mercaptopurine 50 mg tablets in 25 count and 250 count bottles on allocation.
- Quinn has mercaptopurine 50 mg tablets in 25 count and 250 count bottles on back order and the company cannot estimate a release date.
Updated
Updated February 21, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 8, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.